Reply to the letter to the editor 'Cancer survivors: surveillance or not surveillance?' by Santeufemia and Miolo

Affiliations

• ¹ Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo; Department of Medicine, Sørlandet Hospital, Kristiansand.
• ² Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo; Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway; Frontier Science Foundation, Boston.
• ³ Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo; Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
• ⁴ Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo; Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
• ⁵ Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: hadami@hsph.harvard.edu.